Skip to content
10-Q

Quarterly Report

NEUROPATHIX, INC.

0001607062-22-000388

← back to feed
Filed
May 23, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 23, 2022 93.81M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$113.68K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$445.88K
Long Term Debt Q1 2022 · Mar 31, 2022 $107.91K
Long Term Debt Q1 2022 · Dec 31, 2021 $107.91K
Short Term Debt Q1 2022 · Mar 31, 2022 $42.09K
Short Term Debt Q1 2022 · Dec 31, 2021 $42.09K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $102.19K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $15.68K
Cash And Equivalents Q1 2022 · Mar 31, 2021 $323.19K
Cash And Equivalents Q1 2022 · Dec 31, 2020 $21.87K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$5.25M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$3.99M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$2.74M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$3.19M
Current Liabilities Q1 2022 · Mar 31, 2022 $3.6M
Current Liabilities Q1 2022 · Dec 31, 2021 $2.98M
Total Liabilities Q1 2022 · Mar 31, 2022 $5.64M
Total Liabilities Q1 2022 · Dec 31, 2021 $4.21M
Current Assets Q1 2022 · Mar 31, 2022 $108.43K
Current Assets Q1 2022 · Dec 31, 2021 $138.39K
Total Assets Q1 2022 · Mar 31, 2022 $387.35K
Total Assets Q1 2022 · Dec 31, 2021 $224.7K
Sga Expense Q1 2022 · Mar 31, 2022 $354.58K
Sga Expense Q1 2022 · Mar 31, 2021 $987.19K
Rd Expense Q1 2022 · Mar 31, 2022 $219.76K
Rd Expense Q1 2022 · Mar 31, 2021 $128.65K
Net Income Q1 2022 · Mar 31, 2022 −$1.6M
Net Income Q1 2022 · Mar 31, 2021 −$1.33M
Operating Income Q1 2022 · Mar 31, 2022 −$366.36K
Operating Income Q1 2022 · Mar 31, 2021 −$1.08M
Revenue Q1 2022 · Mar 31, 2022 $207.98K
Revenue Q1 2022 · Mar 31, 2021 $32K
Capex Q1 2022 · Mar 31, 2021 $8.1K